Actively Recruiting
Emotional Dysregulation in Para-suicidal Behavior: Effects of Dialectical Behavioral Therapy on Emotional Processing, a Triangulation Approach
Led by Haukeland University Hospital · Updated on 2019-08-28
60
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
H
Haukeland University Hospital
Lead Sponsor
U
University of Bergen
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are investigating the emotional processing changes related to the treatment of non-suicidal self-injury and suicidal thoughts using Dialectical Behavior Therapy (DBT). This study explores how DBT affects emotion regulation, intensity and frequency of self-harm and suicidal ideation, and includes measurements of anxiety, depression, and impulsivity as common related conditions. A matched control group of healthy individuals is included for comparison. Participants receiving DBT will undergo a standard outpatient program focused on improving emotion regulation skills, which is a manualized therapy addressing maladaptive behaviors like self-injury and suicidal thoughts. The study uses a naturalistic pre-post design with assessments at baseline, week 16, week 32, and upon completion of the approximately one-year DBT program. Healthy controls complete baseline testing only. Throughout the study, participants will complete self-report questionnaires on emotion regulation, mindfulness, self-compassion, anxiety, depression, and impulsivity, alongside psychophysiological testing including heart rate variability to measure emotional regulation capacity. The primary outcomes assessed include changes in suicidal thoughts, self-injury frequency, impulse intensity, and heart rate variability. Data will be analyzed to understand how emotion regulation improves with DBT and how these changes relate to clinical improvements over time.
CONDITIONS
Brief Title
Emotional Dysregulation in Para-suicidal Behavior
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with non-suicidal self-injury and/or suicidal ideation who are undergoing standard outpatient Dialectical Behavior Therapy (DBT) treatment
- Aged between 18 and 65 years
- Able to provide informed consent
You will not qualify if you...
- Lack of informed consent
- For healthy controls: former or current neurological conditions
- For healthy controls: severe psychiatric illness
- For healthy controls: cardiac conditions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants complete baseline assessments including clinical, cognitive, and psychophysiological measures before starting therapy.
1 visit (in-person)
Duration - Approximately 1 year
Participants receive standard Dialectical Behavior Therapy (DBT) aimed at improving emotion regulation and reducing self-harm and suicidal ideation.
Regular therapy sessions over the treatment period
Duration - Up to 1 year from baseline
Participants complete follow-up assessments to measure changes in suicidal thoughts, self-injury behaviors, emotion regulation, and related symptoms.
Assessments at week 16, week 32, and at treatment completion
Trial Site Locations
Total: 1 location
1
Haukeland University Hospital, Bjørgvin DPS
Bergen, Norway, 5009
Actively Recruiting
Research Team
B
Berge Osnes, PhD
L
Lin Sørensen, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here